Baumann Frederic, Hehli Deborah, Makaloski Vladimir, Schumacher Martin, Schönhofen Heinz, Diehm Nicolas
1 Clinical and Interventional Angiology, UniversitätsSpital Zürich, Zurich, Switzerland.
2 Clinic of Internal Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Vasa. 2017 Aug;46(5):347-353. doi: 10.1024/0301-1526/a000627. Epub 2017 May 10.
Erectile dysfunction (ED) is an evolving health problem with growing incidence in the ageing male population with potentially predictive value for cardiovascular and other chronic diseases. ED shares the common cardiovascular risk factors. The aetiology of ED is numerous including neurogenic, psychogenic, arteriogenic, and venogenic reasons. The origin of arteriogenic ED is frequently atherosclerosis. Patients not adequately responding to conservative measures including oral medication are often referred to further vascular diagnostics and therapy. At present, the refinements in endovascular therapy allow for minimal-invasive revascularization of erection-related arteries. The role of endovascular therapy in the complex framework of the multifactorial causes of ED requires further scientific scrutiny.
勃起功能障碍(ED)是一个不断演变的健康问题,在老年男性人群中的发病率不断上升,对心血管疾病和其他慢性疾病具有潜在的预测价值。ED与常见的心血管危险因素相同。ED的病因众多,包括神经源性、心理性、动脉源性和静脉源性原因。动脉源性ED的起源通常是动脉粥样硬化。对包括口服药物在内的保守治疗措施反应不佳的患者通常会接受进一步的血管诊断和治疗。目前,血管内治疗的改进使得与勃起相关动脉的微创血管重建成为可能。血管内治疗在ED多因素病因的复杂框架中的作用需要进一步的科学研究。